Mirati治療 MRTX 深 滬
交易中 10-06 10:30:48 美东时间
58.70
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 58.70
- 總市值 40.08亿
- 52周最高 64.41
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 27.30
- 委 比 0.00%
- 總股本 6827.40万
- 歷史最高 249.42
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.063
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
Merit Medical的SCOUT® Radar Localization已服务75万名患者，助力乳腺癌治疗。该技术精准定位肿瘤，提升手术成功率。SCOUT MD™增加四种反射器形状，进一步提高定位精确度。已获100篇临床研究支持，在50个国家广泛应用，每日超500例。乳腺癌意识月强调早诊早治的重要性。Merit致力于通过创新技术改善患者护理。
10-01 13:25
Maris-Tech Introduces Peridot Night: Advanced Thermal and Day Camera Solution for 360° Situational Awareness
Maris-Tech Ltd. announced the launch of Peridot Night, an AI-driven situational awareness and terrain dominance solution designed to enhance visibility, safety, and operational decision-making for military and homeland security applications. The system integrates thermal and full-HD cameras to deliver seamless panoramic video streams, providing reliable real-time intelligence in demanding environments. Peridot Night can be mounted on various plat...
09-29 12:10
Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines
Monte Rosa Therapeutics has published a groundbreaking study in *Science* detailing how their AI/ML-powered QuEEN™ engine expands the target space for molecular glue degraders (MGDs), identifying over 100 previously undruggable protein targets. These discoveries unlock new opportunities in treating historically intractable diseases in oncology, immunology, and inflammation, demonstrating the engine's ability to design highly selective degrader th...
07-03 18:15
2024 年全球大型药企薪酬最高十位 CEO
（转自：抗体圈） 尽管在 Fierce 的 2024 年制药公司首席执行官薪酬排行榜上出现了许多熟悉的名字，但多位高管的排名发生了巨大变化，而第一名被一位黑马候...
06-18 11:23
昔日千亿市值独角兽，被收购
明星Biotech蓝鸟生物，昔日千亿市值独角兽，最终还是选择了“卖身”。 当地时间2月21日，蓝鸟生物宣布，将被全球投资公司凯雷和由SK Capital管理的基...
02-22 10:17
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
bluebird bio agrees to be acquired by Carlyle Group and SK Capital, offering stockholders up to $9.84 per share in a strategic buyout.
02-21 21:53
百时美施贵宝再推20亿美元成本削减计划
继此前计划到2025年底削减15亿美元开支后，跨国制药企业百时美施贵宝（以下简称BMS）近期又公布了一项成本削减计划，即到2027年底削减20亿美元成本。 B...
02-11 21:43
ALX Oncology names Alan Sandler as chief medical officer
ALX Oncology (NASDAQ:ALXO) said it has appointed Alan Sandler as its chief medical officer. Sandler was formerly the chief medical officer at Mirati Therapeutics. More on ALX Oncology ALX Oncology's E...
2024-11-14 21:15
